FULC
Price
$10.36
Change
+$0.11 (+1.07%)
Updated
Jan 14 closing price
Capitalization
683.45M
42 days until earnings call
Intraday BUY SELL Signals
GPCR
Price
$84.33
Change
+$6.41 (+8.23%)
Updated
Jan 14 closing price
Capitalization
5.94B
70 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FULC vs GPCR

Header iconFULC vs GPCR Comparison
Open Charts FULC vs GPCRBanner chart's image
Fulcrum Therapeutics
Price$10.36
Change+$0.11 (+1.07%)
Volume$726.14K
Capitalization683.45M
Structure Therapeutics
Price$84.33
Change+$6.41 (+8.23%)
Volume$1.79M
Capitalization5.94B
FULC vs GPCR Comparison Chart in %
FULC
Daily Signal:
Gain/Loss:
GPCR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
FULC vs. GPCR commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a Hold and GPCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (FULC: $10.36 vs. GPCR: $84.33)
Brand notoriety: FULC and GPCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 44% vs. GPCR: 98%
Market capitalization -- FULC: $683.45M vs. GPCR: $5.94B
FULC [@Biotechnology] is valued at $683.45M. GPCR’s [@Biotechnology] market capitalization is $5.94B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileGPCR’s FA Score has 0 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • GPCR’s FA Score: 0 green, 5 red.
According to our system of comparison, both FULC and GPCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 4 TA indicator(s) are bullish while GPCR’s TA Score has 3 bullish TA indicator(s).

  • FULC’s TA Score: 4 bullish, 6 bearish.
  • GPCR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, GPCR is a better buy in the short-term than FULC.

Price Growth

FULC (@Biotechnology) experienced а +3.81% price change this week, while GPCR (@Biotechnology) price change was +27.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

FULC is expected to report earnings on Feb 26, 2026.

GPCR is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GPCR($5.94B) has a higher market cap than FULC($683M). GPCR YTD gains are higher at: 21.251 vs. FULC (-8.400). FULC has higher annual earnings (EBITDA): -80.09M vs. GPCR (-246.42M). GPCR has more cash in the bank: 799M vs. FULC (201M). FULC (7.01M) and GPCR (7.09M) have identical debt. FULC (0) and GPCR (0) have equivalent revenues.
FULCGPCRFULC / GPCR
Capitalization683M5.94B11%
EBITDA-80.09M-246.42M33%
Gain YTD-8.40021.251-40%
P/E RatioN/AN/A-
Revenue00-
Total Cash201M799M25%
Total Debt7.01M7.09M99%
FUNDAMENTALS RATINGS
FULC: Fundamental Ratings
FULC
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FULCGPCR
RSI
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 25 days ago
88%
Bullish Trend 3 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 11 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
FULC
Daily Signal:
Gain/Loss:
GPCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFREX40.760.36
+0.89%
DFA Real Estate Securities I
HMCLX16.430.06
+0.37%
Harbor Mid Cap Institutional
NEQAX13.18-0.02
-0.15%
Neuberger U.S. Equity Impact A
RGGYX28.58-0.09
-0.31%
Victory RS Global Y
UMLGX6.97-0.09
-1.27%
Columbia Select Large Cap Growth Inst

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with WVE. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
+1.07%
WVE - FULC
55%
Loosely correlated
+2.04%
OCUL - FULC
49%
Loosely correlated
+6.14%
GPCR - FULC
49%
Loosely correlated
+8.23%
SLS - FULC
48%
Loosely correlated
-0.96%
KRRO - FULC
43%
Loosely correlated
+0.11%
More

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been closely correlated with WVE. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if GPCR jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
+8.23%
WVE - GPCR
69%
Closely correlated
+2.04%
KYMR - GPCR
50%
Loosely correlated
+1.46%
FULC - GPCR
49%
Loosely correlated
+1.07%
OCUL - GPCR
47%
Loosely correlated
+6.14%
NRIX - GPCR
43%
Loosely correlated
+0.58%
More